PIK3CB and non-small cell lung carcinoma: Similarly, miR-4299 expression was reduced in NSCLC tissues and cells, especially during disease progression, and overexpression of miR-4299 could inactivate the AKT/PI3K pathway to exert tumor suppressor effects (52).